It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

Colossal Biosciences, which aims to revive extinct species, announced it has raised an additional $200 million. Critics say ...

In BlueAllele Corp. v. Intellia Therapeutics, Inc., 2024 U.S. Dist. Lexis 222094 (D. Del. Dec. 9, 2024)1, the District of ...

Cancer is a terrifying diagnosis. The second-leading cause of death in the United States drains $25 trillion a year from the ...

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

Panelists from China, India, and Vietnam speak about the threat the fungal disease poses on each country and the best ...

Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new ...

Touchlight, an innovation-driven Contract Development and Manufacturing Organisation (CDMO), today announced that its facility in Hampton UK has received GMP certification. As a result, Touchlight ...

This method edits the HBG1 and HBG2 promoter regions ... The growing demand for gene therapeutics, advancements in genome editing technologies, and expanded applications in diagnostics and agriculture ...

Two Nebraska researchers have launched a startup company aimed at bringing to market an innovative method for delivering therapeutics, gene editing tools, plasmids and more to targeted locations in ...

These methods often require robotics ... CRISPR–Cas9-based saturation genome editing in a humanized mouse embryonic stem cell line was used for comprehensive functional characterization of ...